Novel methods for the quantification of toxic, residual phase transfer catalyst in fluorine-18 labeled radiotracers

被引:4
|
作者
Blevins, David W. [1 ]
Rigney, Grant H. [1 ,2 ]
Fang, Michael Y. [1 ,2 ]
Akula, Murthy R. [1 ]
Osborne, Dustin R. [1 ]
机构
[1] Univ Tennessee, Grad Sch Med, 1929 Alcoa Hwy, Knoxville, TN 37920 USA
[2] Univ Tennessee, Dept Mech Aerosp & Biomed Engn, Knoxville, TN USA
关键词
Absorbance; Conductance; Phase-transfer-catalyst; Radiopharmaceutical; Transmittance; CROWN-ETHERS; COMPLEX-FORMATION; KRYPTOFIX; 2.2.2; ALKALI; TETRABUTYLAMMONIUM; CHROMATOGRAPHY; CRYPTANDS; METAL; IONS; FDG;
D O I
10.1016/j.nucmedbio.2019.07.008
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Introduction: Fluorine-18 labeled radiopharmaceuticals undergo quality control testing for residual phase-transfer-catalyst content. The almost universally used quality-control test is a silica plate spot-test comparison of the radiopharmaceutical beside a 50-ppm standard. Once developed by staining, the radiopharmaceutical spot must be of equal or less intensity to pass the test. There is currently a need for a quantitative, inexpensive, and less subjective quality control method that allows the automatic incorporation of the acquired measurement directly into electronic batch reports. Results: In the developed method, a resazurin test solution is mixed with an aliquot of the radiopharmaceutical analyte along with dichloromethane (DCM). The mixture is vortexed. The potassium resazurin-phase transfer catalyst complex solubilizes into the DCM imparting a blue color. The organic layer is then removed for analysis. Three measurement methods were utilized: visual colorimetry against pre-prepared standards, spectrophotometric measurement of transmittance, and electrical conductance. A simple prototype spectrophotometer and an electrical test cell were constructed to acquire data. Sodium Resazurin dye was found to be a suitable test chromophore for residual phase transfer catalyst analysis of aqueous solutions. Quantitative spectrophotometric measurements are possible in the 0-100-ppm range (18-crown-6) and 0-150-ppm range (Kryptofix (R) or tetrabutylammonium). Electrical resistance measurements of the phase transfer-catalyst resazurin complex in DCM are also a viable method, allowing quantitative phase transfer catalyst measurements in the 0-100-ppm range. Conclusion: The methodologies developed are more quantitative alternatives to the current spot-test method. The spectrophotometric method was determined to be the most accurate method. (C) 2019 The Authors. Published by Elsevier Inc.
引用
收藏
页码:41 / 48
页数:8
相关论文
共 43 条
  • [21] Novel fluorine-18 labeled 2-arylquinoline derivatives for imaging tau-pathology in Alzheimer's disease
    Furumoto, Shozo
    Okamura, Nobuyuki
    Fodero-Tavoletti, Michelle
    Villemagne, Victor
    Harada, Ryuichi
    Tago, Tetsuro
    Iwata, Ren
    Yanai, Kazuhiko
    Kudo, Yukitsuka
    JOURNAL OF NUCLEAR MEDICINE, 2012, 53
  • [22] Single-step radiosynthesis and in vivo evaluation of a novel fluorine-18 labeled hippurate for use as a PET renal agent
    Pathuri, Gopal
    Hedrick, Andria
    Awasthi, Vibhudutta
    Gali, Hariprasad
    JOURNAL OF NUCLEAR MEDICINE, 2012, 53
  • [23] Development of novel fluorine-18 labeled PET tracers for imaging the metabotropic glutamate receptor subtype 5 (mGluR5)
    Baumann, C. A.
    Mu, L.
    Johannsen, S.
    Lucatelli, C.
    Honer, M.
    Schubiger, A. P.
    Ametamey, S. M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 : S208 - S209
  • [24] DEVELOPMENT OF NOVEL FLUORINE-18 LABELED PET TRACERS FOR IMAGING THE METABOTROPIC GLUTAMATE RECEPTOR SUBTYPE 5 (MGLUR5)
    Baumann, C. A.
    Mu, L.
    Johannsen, S.
    Wertli, N.
    Honer, M.
    Ametamey, S. M.
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2009, 52 : S339 - S339
  • [25] Development and preparation of novel carbon-11/fluorine-18 containing radiotracers for non-invasive PET-imaging of EphB4
    Mamat, Constantin
    Ebert, Kristin
    Caballero, Julio
    Pietzsch, Jens
    Steinbach, Joerg
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2013, 56 : S400 - S400
  • [26] Synthesis and biological evaluation of novel propargyl amines as potential fluorine-18 labeled radioligands for detection of MAO-B activity
    Nag, S.
    Kettschau, G.
    Heinrich, T.
    Varrone, A.
    Lehmann, L.
    Gulyas, B.
    Thiele, A.
    Keller, E.
    Halldin, C.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2013, 21 (01) : 186 - 195
  • [27] [18F]D2-LW223: a novel fluorine-18 labeled deuterated radiotracer for investigating imaging Translocator protein 18 kDa (TSPO)
    Wang, Lu
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65
  • [28] First-in-Human PET studies with CTT1057, a novel fluorine-18 labeled agent targeting PSMA in prostate cancer
    Behr, Spencer
    Aggarwal, Rahul
    Seo, Youngho
    Gao, Kenneth
    Ravanfar, Vahid
    Slater, James
    Jivan, Salma
    Blecha, Joseph
    Langton-Webster, Beatrice
    Berkman, Clifford
    VanBrocklin, Henry
    JOURNAL OF NUCLEAR MEDICINE, 2017, 58
  • [29] A novel fluorine-18 labeled P2Y12 receptor PET tracer for imaging of anti-inflammatory microglia
    van der Wildt, Berend
    Steen, E. Johanna
    Janssen, Bieneke
    Kooijman, Esther
    Schreurs, Maxime
    Vugts, Danielle
    Windhorst, Albert
    NUCLEAR MEDICINE AND BIOLOGY, 2022, 108 : S108 - S109
  • [30] ZW-102 AND ZW-104, TWO NOVEL FLUORINE-18 LABELED RADIOLIGANDS FOR IMAGING NICOTINIC ACETYLCHOLINE RECEPTORS WITH PET
    Dolle, F.
    Damont, A.
    Valette, H.
    Hinnen, F.
    Kuhnast, B.
    Saba, W.
    Schollhorn-Peyronneau, M.
    Kozikowski, A.
    Bottlaender, M.
    Kassiou, M.
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2009, 52 : S364 - S364